OMB
.report
Search
AER under FFDCA sec. 760 - nonprescription drug products
Postmarketing Adverse Drug Experience Reporting
0701 AER Pandemic GFI 2020
AER under FFDCA sec. 760 - nonprescription drug products
OMB: 0910-0230
OMB.report
HHS/FDA
OMB 0910-0230
ICR 202303-0910-017
IC 234419
AER under FFDCA sec. 760 - nonprescription drug products
( )
Document [file]
Download:
file
|
pdf
File Type
inode/x-empty
© 2024 OMB.report |
Privacy Policy